)

Cryoport (CYRX) investor relations material
Cryoport Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Q2 2025 revenue rose 14–14.5% year-over-year to $45.5M, with double-digit growth in Life Sciences Services and Products, and notable gains in BioStorage/BioServices and BioLogistics Solutions.
Strategic partnership with DHL Group completed, including the divestiture of CRYOPDP, resulting in a $116.7M–$117.4M gain and enhanced global biologistics capabilities.
Supported 728 active clinical trials and 18 commercial therapies globally as of June 30, 2025, with 82 in Phase III.
Commercial Cell & Gene Therapy revenue increased 32–33% year-over-year to $8.7M, with BioStorage/BioServices up 28%.
Net income for Q2 2025 was $105.2M, primarily due to the CRYOPDP sale gain.
Financial highlights
Gross margin improved to 47% in Q2 2025, up from 44.5% in Q2 2024.
Adjusted EBITDA from continuing operations improved to negative $0.9M from negative $5.6M year-over-year.
Life Sciences Services revenue was $24.4M (54% of total), up 21% year-over-year; Products revenue was $21.1M, up 8%.
Cash, cash equivalents, and short-term investments totaled $426M as of June 30, 2025.
Net income margin for Q2 2025 was 231.3%, driven by the one-time CRYOPDP gain.
Outlook and guidance
Full-year 2025 revenue guidance reaffirmed at $165M–$172M, representing 5–10% year-over-year growth.
Guidance reflects a $2M revenue impact from a client’s temporary therapy pause and no expected market recovery in China for 2025.
Management expects cost reduction and capital realignment to return the business to positive adjusted EBITDA during 2025.
Guidance for 2026 will be provided at year-end; outlook includes expectations for additional BLA/MAA filings and approvals.
Gross margins expected to remain relatively flat in the second half, with a long-term goal of exceeding 55% gross margin and 30% adjusted EBITDA margin.
Next Cryoport earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage